Annual Retained Earnings
-$136.04 M
-$60.37 M-79.77%
31 December 2023
Summary:
Kyverna Therapeutics Common Stock annual retained earnings is currently -$136.04 million, with the most recent change of -$60.37 million (-79.77%) on 31 December 2023. During the last 3 years, it has fallen by -$89.26 million (-190.79%). KYTX annual retained earnings is now -190.79% below its all-time high of -$46.78 million, reached on 01 December 2021.KYTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$226.03 M
-$34.49 M-18.01%
30 September 2024
Summary:
Kyverna Therapeutics Common Stock quarterly retained earnings is currently -$226.03 million, with the most recent change of -$34.49 million (-18.01%) on 30 September 2024. Over the past year, it has dropped by -$89.99 million (-66.15%). KYTX quarterly retained earnings is now -198.68% below its all-time high of -$75.68 million, reached on 01 December 2022.KYTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KYTX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -66.2% |
| 3 y3 years | -190.8% | - |
| 5 y5 years | - | - |
KYTX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -190.8% | at low | -198.7% | at low |
| 5 y | 5 years | -190.8% | at low | -198.7% | at low |
| alltime | all time | -190.8% | at low | -198.7% | at low |
Kyverna Therapeutics Common Stock Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$226.03 M(+18.0%) |
| June 2024 | - | -$191.54 M(+17.7%) |
| Mar 2024 | - | -$162.74 M(+19.6%) |
| Dec 2023 | -$136.04 M | -$136.04 M(+17.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | -$115.38 M(+52.5%) |
| Dec 2022 | -$75.68 M(+61.8%) | - |
| Dec 2022 | - | -$75.68 M |
| Dec 2021 | -$46.78 M | - |
FAQ
- What is Kyverna Therapeutics Common Stock annual retained earnings?
- What is the all time high annual retained earnings for Kyverna Therapeutics Common Stock?
- What is Kyverna Therapeutics Common Stock quarterly retained earnings?
- What is the all time high quarterly retained earnings for Kyverna Therapeutics Common Stock?
- What is Kyverna Therapeutics Common Stock quarterly retained earnings year-on-year change?
What is Kyverna Therapeutics Common Stock annual retained earnings?
The current annual retained earnings of KYTX is -$136.04 M
What is the all time high annual retained earnings for Kyverna Therapeutics Common Stock?
Kyverna Therapeutics Common Stock all-time high annual retained earnings is -$46.78 M
What is Kyverna Therapeutics Common Stock quarterly retained earnings?
The current quarterly retained earnings of KYTX is -$226.03 M
What is the all time high quarterly retained earnings for Kyverna Therapeutics Common Stock?
Kyverna Therapeutics Common Stock all-time high quarterly retained earnings is -$75.68 M
What is Kyverna Therapeutics Common Stock quarterly retained earnings year-on-year change?
Over the past year, KYTX quarterly retained earnings has changed by -$89.99 M (-66.15%)